These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. BM-derived stem cells for the treatment of nonhematopoietic diseases. Krause DS Cytotherapy; 2002; 4(6):503-6. PubMed ID: 12568982 [No Abstract] [Full Text] [Related]
24. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632 [TBL] [Abstract][Full Text] [Related]
25. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation. Fang B; Song Y; Li N; Li J; Han Q; Zhao RC Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919 [TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine. Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990 [TBL] [Abstract][Full Text] [Related]
28. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation. You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355 [TBL] [Abstract][Full Text] [Related]
29. A new bone marrow transplantation method for stem cell disorders. Ikehara S Ann N Y Acad Sci; 2009 Sep; 1173():774-80. PubMed ID: 19758228 [TBL] [Abstract][Full Text] [Related]
30. [Allogeneic stem cell transplantation for patients with Philadelphia positive leukemia resistant to imatinib]. Han W; Liu KY; Xu LP; Chen H; Liu DH; Chen YH; Zhang XH; Zhang YC; Chen Y; Wang Y; Wang J; Lu DP; Huang XJ Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1974-7. PubMed ID: 19062738 [TBL] [Abstract][Full Text] [Related]
31. Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation. Ito T; Makishima H; Nakazawa H; Kobayashi H; Shimodaira S; Nakazawa Y; Kitano K; Matsuda K; Hidaka E; Ishida F Eur J Haematol; 2008 Aug; 81(2):107-11. PubMed ID: 18462253 [TBL] [Abstract][Full Text] [Related]
32. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation. Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519 [TBL] [Abstract][Full Text] [Related]
33. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin. Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944 [TBL] [Abstract][Full Text] [Related]
34. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G; Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401 [TBL] [Abstract][Full Text] [Related]
35. [Tissue typing of potential stem cell and bone marrow donors--2: Courage and engagement required]. Burbach M Pflege Z; 2008 Jun; 61(6):308-9. PubMed ID: 18605609 [No Abstract] [Full Text] [Related]
37. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation. Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024 [TBL] [Abstract][Full Text] [Related]
38. Haploidentical hematopoietic stem cell transplantation in child hematologic malignancies with G-CSF-mobilized marrow grafts without T-cell depletion: a single-center report of 45 cases. Wang HX; Yan HM; Duan LN; Wang ZD; Zhu L; Xue M; Liu J; Hu LD; Guo ZK Pediatr Hematol Oncol; 2009; 26(3):119-28. PubMed ID: 19382033 [TBL] [Abstract][Full Text] [Related]
39. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes. Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248 [TBL] [Abstract][Full Text] [Related]
40. Autologous hematopoietic stem cell transplantation for type 1 diabetes. Voltarelli JC; Couri CE; Stracieri AB; Oliveira MC; Moraes DA; Pieroni F; Barros GM; Madeira MI; Malmegrim KC; Foss-Freitas MC; Simões BP; Foss MC; Squiers E; Burt RK Ann N Y Acad Sci; 2008 Dec; 1150():220-9. PubMed ID: 19120300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]